Fairfield, CT, United States of America

Steven M Bilodeau

This inventor holds 42 USPTO granted patents and 10 published patent applications and 2 EPO patents, primarily in Silicon Etching. Top assignees: Advanced Technology Materials, Inc., Entegris, Inc.. Active years: 1999-2026.

USPTO Granted Patents = 42 

% Patents Active = 71.4

 

Average Co-Inventor Count = 3.5

ph-index = 9

Forward Citations = 1,081(Granted Patents)


Location History:

  • Newtown, CT (US) (1999 - 2003)
  • Billerica, MA (US) (2021)
  • Oxford, CT (US) (1999 - 2024)
  • Fairfield, CT (US) (2021 - 2024)

Company Filing History:


Years Active: 1999-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Silicon Nitride
Etching Compositions
Chemical Vapor Deposition
Ferroelectric Memory
Thin Films
Silicon-Germanium
PZT Materials
Stress Control
Wet Etching
Lithographic Tools
Polysilicon
Solar Refrigeration
42 patents (USPTO):Explore Patents

Title: The Innovative Journey of Steven M. Bilodeau

Introduction: Steven M. Bilodeau, a talented inventor hailing from Fairfield, CT, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Steven M. Bilodeau holds several patents in various fields, including telecommunications, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Steven M. Bilodeau has worked with renowned companies in the tech industry, leading research and development teams to bring cutting-edge products to the market.

Collaborations: Throughout his career, Steven M. Bilodeau has collaborated with top researchers, engineers, and scientists, fostering a culture of innovation and excellence in all his projects.

Conclusion: Steven M. Bilodeau's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and entrepreneurs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…